1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow SeSAME syndrome: new trials by email Literature Review of SeSAME syndrome trials Research Report on SeSAME syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy linvoseltamab, dupilumab - Food Allergy | Phase 1 | Active not recruiting | Regeneron Pharmaceuticals | 6 | 2024-05-17 | 2026-06-26 |
Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1)
dupilumab (1)
United States (1)